{
    "clinical_study": {
        "@rank": "124634", 
        "brief_summary": {
            "textblock": "RATIONALE: Gabapentin may be effective for the control of hot flashes. It is not yet known\n      if gabapentin is effective in treating hot flashes.\n\n      PURPOSE: Randomized clinical trial to study the effectiveness of gabapentin in controlling\n      hot flashes in women who have breast cancer."
        }, 
        "brief_title": "Gabapentin For the Control of Hot Flashes in Women With Breast Cancer", 
        "completion_date": {
            "#text": "June 2005", 
            "@type": "Actual"
        }, 
        "condition": [
            "Anxiety Disorder", 
            "Breast Cancer", 
            "Depression", 
            "Hot Flashes"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Anxiety Disorders", 
                "Breast Neoplasms", 
                "Depression", 
                "Depressive Disorder", 
                "Hot Flashes"
            ]
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES:\n\n        -  Compare the effectiveness and side effects of 2 different doses of gabapentin vs\n           placebo for the control of hot flashes and other vasomotor symptoms in women with\n           breast cancer.\n\n        -  Compare quality of life, anxiety, and depression in patients treated with these\n           regimens.\n\n      OUTLINE: This is a randomized, double-blind, placebo-controlled, multicenter study. Patients\n      are stratified according to participating center and duration of hot flash symptoms (less\n      than 9 months vs 9 or more months). Patients are randomized to 1 of 3 arms.\n\n        -  Arm I: Patients receive oral placebo 3 times a day.\n\n        -  Arm II: Patients receive oral gabapentin at a low dose 3 times a day.\n\n        -  Arm III: Patients receive oral gabapentin as in arm II for 3 days and then at a high\n           dose 3 times a day.\n\n      Treatment on all arms continues for 8 weeks in the absence of unacceptable toxicity. After\n      week 8, patients may receive open-label gabapentin at the discretion of their physicians.\n\n      Hot flashes are assessed at baseline and then during weeks 3 and 7 of the study.\n\n      Quality of life, anxiety, and depression are assessed at baseline and then at weeks 4 and 8.\n\n      Patients are followed at week 12.\n\n      PROJECTED ACCRUAL: A total of 408 patients (136 per arm) will be accrued for this study\n      within 18 months."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS:\n\n          -  Diagnosis of breast cancer\n\n          -  Experiencing 2 or more hot flashes per day for at least 1 week\n\n          -  Hormone receptor status:\n\n               -  Not specified\n\n        PATIENT CHARACTERISTICS:\n\n        Age:\n\n          -  Not specified\n\n        Sex:\n\n          -  Female\n\n        Menopausal status:\n\n          -  Not specified\n\n        Performance status:\n\n          -  Not specified\n\n        Life expectancy:\n\n          -  Not specified\n\n        Hematopoietic:\n\n          -  Not specified\n\n        Hepatic:\n\n          -  Bilirubin normal\n\n          -  SGOT no greater than 2 times upper limit of normal (ULN)\n\n        Renal:\n\n          -  Creatinine no greater than 1.25 times ULN\n\n        Cardiovascular:\n\n          -  No coronary insufficiency\n\n          -  No myocardial infarction within the past 3 months\n\n          -  No symptomatic cardiac disease\n\n          -  No peripheral vascular disease\n\n          -  No cerebrovascular disease or stroke\n\n          -  No syncope or symptomatic hypotension\n\n        Other:\n\n          -  No history of allergic or other adverse reaction to gabapentin\n\n          -  Not pregnant or nursing\n\n          -  Fertile patients must use effective contraception during and for 1 week after study\n\n        PRIOR CONCURRENT THERAPY:\n\n        Biologic therapy\n\n          -  Not specified\n\n        Chemotherapy\n\n          -  Not specified\n\n        Endocrine therapy\n\n          -  Not specified\n\n        Radiotherapy\n\n          -  Not specified\n\n        Surgery\n\n          -  Not specified\n\n        Other\n\n          -  No other concurrent anticonvulsant medication\n\n          -  No concurrent clonidine or venlafaxine"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "firstreceived_date": "August 10, 2001", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00022074", 
            "org_study_id": "CDR0000068780", 
            "secondary_id": [
                "URCC-U2101", 
                "NCI-P01-0183"
            ]
        }, 
        "intervention": [
            {
                "intervention_name": "gabapentin", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "quality-of-life assessment", 
                "intervention_type": "Procedure"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Gabapentin"
        }, 
        "keyword": [
            "stage I breast cancer", 
            "stage II breast cancer", 
            "stage IV breast cancer", 
            "stage IIIA breast cancer", 
            "recurrent breast cancer", 
            "stage IIIB breast cancer", 
            "stage IIIC breast cancer", 
            "anxiety disorder", 
            "depression", 
            "hot flashes"
        ], 
        "lastchanged_date": "March 4, 2013", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/URCC-U2101"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Mobile", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "36688"
                    }, 
                    "name": "MBCCOP - Gulf Coast"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Phoenix", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85006-2726"
                    }, 
                    "name": "CCOP - Greater Phoenix"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Scottsdale", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85259-5404"
                    }, 
                    "name": "CCOP - Scottsdale Oncology Program"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Denver", 
                        "country": "United States", 
                        "state": "Colorado", 
                        "zip": "80224"
                    }, 
                    "name": "CCOP - Colorado Cancer Research Program, Incorporated"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Honolulu", 
                        "country": "United States", 
                        "state": "Hawaii", 
                        "zip": "96813"
                    }, 
                    "name": "MBCCOP - Hawaii"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Decatur", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "62526"
                    }, 
                    "name": "CCOP - Central Illinois"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wichita", 
                        "country": "United States", 
                        "state": "Kansas", 
                        "zip": "67214-3882"
                    }, 
                    "name": "CCOP - Wichita"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kalamazoo", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "49007-3731"
                    }, 
                    "name": "CCOP - Kalamazoo"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saint Louis Park", 
                        "country": "United States", 
                        "state": "Minnesota", 
                        "zip": "55416"
                    }, 
                    "name": "CCOP - Metro-Minnesota"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hackensack", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "07601"
                    }, 
                    "name": "CCOP - Northern New Jersey"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Manhasset", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11030"
                    }, 
                    "name": "CCOP - North Shore University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Syracuse", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "13217"
                    }, 
                    "name": "CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Winston-Salem", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27104-4241"
                    }, 
                    "name": "CCOP - Southeast Cancer Control Consortium"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Columbus", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "43206"
                    }, 
                    "name": "CCOP - Columbus"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dayton", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45429"
                    }, 
                    "name": "CCOP - Dayton"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seattle", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98101"
                    }, 
                    "name": "CCOP - Virginia Mason Research Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tacoma", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98405-0986"
                    }, 
                    "name": "CCOP - Northwest"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Marshfield", 
                        "country": "United States", 
                        "state": "Wisconsin", 
                        "zip": "54449"
                    }, 
                    "name": "CCOP - Marshfield Medical Research and Education Foundation"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Control of Vasomotor Symptoms in Women Treated for Breast Cancer", 
        "overall_official": {
            "affiliation": "James P. Wilmot Cancer Center", 
            "last_name": "Kishan J. Pandya, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2005", 
            "@type": "Actual"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00022074"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Rochester", 
            "investigator_full_name": "Gary Morrow", 
            "investigator_title": "Director, URCC CCOP Research Base", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "results_reference": {
            "PMID": "16139656", 
            "citation": "Pandya KJ, Morrow GR, Roscoe JA, Zhao H, Hickok JT, Pajon E, Sweeney TJ, Banerjee TK, Flynn PJ. Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. Lancet. 2005 Sep 3-9;366(9488):818-24."
        }, 
        "source": "University of Rochester", 
        "sponsors": {
            "collaborator": {
                "agency": "National Cancer Institute (NCI)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Gary Morrow", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2001", 
        "study_design": "Allocation: Randomized, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }, 
    "geocoordinates": {
        "CCOP - Central Illinois": "39.84 -88.955", 
        "CCOP - Colorado Cancer Research Program, Incorporated": "39.739 -104.985", 
        "CCOP - Columbus": "39.961 -82.999", 
        "CCOP - Dayton": "39.759 -84.192", 
        "CCOP - Greater Phoenix": "33.448 -112.074", 
        "CCOP - Kalamazoo": "42.292 -85.587", 
        "CCOP - Marshfield Medical Research and Education Foundation": "44.669 -90.172", 
        "CCOP - Metro-Minnesota": "44.96 -93.37", 
        "CCOP - North Shore University Hospital": "40.798 -73.7", 
        "CCOP - Northern New Jersey": "40.886 -74.043", 
        "CCOP - Northwest": "47.253 -122.444", 
        "CCOP - Scottsdale Oncology Program": "33.494 -111.926", 
        "CCOP - Southeast Cancer Control Consortium": "36.1 -80.244", 
        "CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C.": "43.048 -76.147", 
        "CCOP - Virginia Mason Research Center": "47.606 -122.332", 
        "CCOP - Wichita": "37.692 -97.337", 
        "MBCCOP - Gulf Coast": "30.694 -88.043", 
        "MBCCOP - Hawaii": "21.307 -157.858"
    }
}